Highlighting concerns with the pharmaceutical supply chain, the Food and Drug Administration warned McKesson, one of the nation’s largest wholesalers, for failing to properly handle episodes where pharmacies received tampered medicines, including three instances in which bottles contained naproxen instead of oxycodone, the highly addictive painkiller.

Specifically, the agency found that McKesson responded inadequately and demonstrated a lack of understanding of key regulations, according to a Feb. 7 warning letter. Notably, the letter is the first such missive issued under the Drug Supply Chain Security Act and also figured prominently in fresh remarks Tuesday by FDA Commissioner Scott Gottlieb about the ongoing opioid crisis.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • This was only acted on, becuse it was an opiate that was stolen from the supply chain. These malicious actors are usually not this inept. Other drug repalcemtns would not have gotten a second glance.

  • Fines should be set as # of days of GROSS REVENUES, eg, 10 days or 30days or in case of major harm or death, in years or even disincorporation…
    After all, if corporations are “persons”, then let the CEOs serve thetime along with the fines!!

  • $150 million is peanuts, McKesson should be held liable, criminally for prescription opioid overdose deaths as well as ruined lives from substance use disorder.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy